{"title":"热消融、常规/开放式甲状腺切除术和内镜下甲状腺切除术治疗症状性良性甲状腺结节的疗效、安全性和患者满意度的比较","authors":"Xiao-Wan Bo, Feng Lu, Song-Yuan Yu, Wen-Wen Yue, Xiao-Long Li, Man Hu, Li-Li Wu, Zhu-Ying Lv, Li-Ping Sun, Hui-Xiong Xu","doi":"10.1080/02656736.2022.2040608","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Thermal ablation (TA) is a minimally invasive treatment method for symptomatic benign thyroid nodules (BTNs). This study aimed to evaluate the value of TA by comparing the efficacy, safety, and patient satisfaction with conventional/open thyroidectomy (ConT) and endoscopic thyroidectomy (ET) for symptomatic BTNs.</p><p><strong>Methods: </strong>Patients with symptomatic BTNs who underwent ConT, ET, or TA therapy between January 2018 and January 2020 were included. Pre-operation data of the two comparisons (TA <i>vs.</i> ConT and TA <i>vs.</i> ET) was balanced using propensity score matching. The technique efficacy (volume reduction ratio ≥50%), nodule disappearance, and regrowth rate were calculated after ablation. The operation and hospitalization time, medical cost, complications, post-operative symptoms, and cosmetic scores were recorded and compared. Patient satisfaction was evaluated using a telephone survey.</p><p><strong>Results: </strong>After a median 19-month follow-up (range, 12-36 months), the technique efficacy rate, nodule disappearance, and regrowth rate were 93.2% (119/129), 6.8% (10/129), and 0.8% (1/129), respectively. Operation time, hospitalization time, and medical costs were less for patients in the TA group than for patients in the ConT and ET groups (all <i>p</i> < 0.001). The incidence of complications, post-operative symptoms, cosmetic scores, and overall satisfaction were not significantly different among groups (all <i>p</i> > 0.05). Post-operative hypothyroidism was less frequent in the TA group than in the ConT and ET groups (all <i>p</i> < 0.05).</p><p><strong>Conclusions: </strong>Compared to ConT and ET, TA has comparable efficacy, safety, and patient satisfaction and exhibits greater protection of thyroid function for the treatment of symptomatic BTNs.</p>","PeriodicalId":520653,"journal":{"name":"International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group","volume":" ","pages":"379-389"},"PeriodicalIF":3.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"Comparison of efficacy, safety, and patient satisfaction between thermal ablation, conventional/open thyroidectomy, and endoscopic thyroidectomy for symptomatic benign thyroid nodules.\",\"authors\":\"Xiao-Wan Bo, Feng Lu, Song-Yuan Yu, Wen-Wen Yue, Xiao-Long Li, Man Hu, Li-Li Wu, Zhu-Ying Lv, Li-Ping Sun, Hui-Xiong Xu\",\"doi\":\"10.1080/02656736.2022.2040608\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Thermal ablation (TA) is a minimally invasive treatment method for symptomatic benign thyroid nodules (BTNs). This study aimed to evaluate the value of TA by comparing the efficacy, safety, and patient satisfaction with conventional/open thyroidectomy (ConT) and endoscopic thyroidectomy (ET) for symptomatic BTNs.</p><p><strong>Methods: </strong>Patients with symptomatic BTNs who underwent ConT, ET, or TA therapy between January 2018 and January 2020 were included. Pre-operation data of the two comparisons (TA <i>vs.</i> ConT and TA <i>vs.</i> ET) was balanced using propensity score matching. The technique efficacy (volume reduction ratio ≥50%), nodule disappearance, and regrowth rate were calculated after ablation. The operation and hospitalization time, medical cost, complications, post-operative symptoms, and cosmetic scores were recorded and compared. Patient satisfaction was evaluated using a telephone survey.</p><p><strong>Results: </strong>After a median 19-month follow-up (range, 12-36 months), the technique efficacy rate, nodule disappearance, and regrowth rate were 93.2% (119/129), 6.8% (10/129), and 0.8% (1/129), respectively. Operation time, hospitalization time, and medical costs were less for patients in the TA group than for patients in the ConT and ET groups (all <i>p</i> < 0.001). The incidence of complications, post-operative symptoms, cosmetic scores, and overall satisfaction were not significantly different among groups (all <i>p</i> > 0.05). Post-operative hypothyroidism was less frequent in the TA group than in the ConT and ET groups (all <i>p</i> < 0.05).</p><p><strong>Conclusions: </strong>Compared to ConT and ET, TA has comparable efficacy, safety, and patient satisfaction and exhibits greater protection of thyroid function for the treatment of symptomatic BTNs.</p>\",\"PeriodicalId\":520653,\"journal\":{\"name\":\"International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group\",\"volume\":\" \",\"pages\":\"379-389\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/02656736.2022.2040608\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/02656736.2022.2040608","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6
摘要
目的:热消融(TA)是治疗症状性良性甲状腺结节(BTNs)的一种微创治疗方法。本研究旨在通过比较常规/开放式甲状腺切除术(ConT)和内窥镜甲状腺切除术(ET)治疗症状性btn的疗效、安全性和患者满意度来评估TA的价值。方法:纳入2018年1月至2020年1月期间接受ConT、ET或TA治疗的症状性btn患者。两种比较(TA vs. ConT和TA vs. ET)的术前数据采用倾向评分匹配进行平衡。计算消融后的技术效果(体积缩小率≥50%)、结节消失率和再生长率。记录手术和住院时间、医疗费用、并发症、术后症状和美容评分并进行比较。通过电话调查评估患者满意度。结果:中位随访19个月(范围12-36个月),技术有效率93.2%(119/129),结节消失率6.8%(10/129),再生长率0.8%(1/129)。TA组患者手术时间、住院时间、医疗费用均少于ConT组和ET组(p < 0.05)。与ConT和ET组相比,TA组术后甲状腺功能减退的发生率较低(均p)结论:与ConT和ET组相比,TA具有相当的疗效、安全性和患者满意度,并且在治疗症状性BTNs方面表现出更大的甲状腺功能保护作用。
Comparison of efficacy, safety, and patient satisfaction between thermal ablation, conventional/open thyroidectomy, and endoscopic thyroidectomy for symptomatic benign thyroid nodules.
Purpose: Thermal ablation (TA) is a minimally invasive treatment method for symptomatic benign thyroid nodules (BTNs). This study aimed to evaluate the value of TA by comparing the efficacy, safety, and patient satisfaction with conventional/open thyroidectomy (ConT) and endoscopic thyroidectomy (ET) for symptomatic BTNs.
Methods: Patients with symptomatic BTNs who underwent ConT, ET, or TA therapy between January 2018 and January 2020 were included. Pre-operation data of the two comparisons (TA vs. ConT and TA vs. ET) was balanced using propensity score matching. The technique efficacy (volume reduction ratio ≥50%), nodule disappearance, and regrowth rate were calculated after ablation. The operation and hospitalization time, medical cost, complications, post-operative symptoms, and cosmetic scores were recorded and compared. Patient satisfaction was evaluated using a telephone survey.
Results: After a median 19-month follow-up (range, 12-36 months), the technique efficacy rate, nodule disappearance, and regrowth rate were 93.2% (119/129), 6.8% (10/129), and 0.8% (1/129), respectively. Operation time, hospitalization time, and medical costs were less for patients in the TA group than for patients in the ConT and ET groups (all p < 0.001). The incidence of complications, post-operative symptoms, cosmetic scores, and overall satisfaction were not significantly different among groups (all p > 0.05). Post-operative hypothyroidism was less frequent in the TA group than in the ConT and ET groups (all p < 0.05).
Conclusions: Compared to ConT and ET, TA has comparable efficacy, safety, and patient satisfaction and exhibits greater protection of thyroid function for the treatment of symptomatic BTNs.